PMID: 17062234
Question: Surgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?
Correct Answer: no

======================= Launch the MCC process =======================
PMID: 17062234
Question: Surgical management of the atherosclerotic ascending aorta: is endoaortic balloon occlusion safe?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The question investigates whether endoaortic balloon occlusion is a safe method for the surgical management of the atherosclerotic ascending aorta.
- **Key Information to Look For:**
  - Effectiveness of endoaortic balloon occlusion compared to conventional cross-clamping.
  - Rates of adverse outcomes such as in-hospital death and stroke.
  - Statistical significance and reliability of the results.

**2. Evidence Evaluation**
- **Research Results and Data:**
  - Endoaortic balloon occlusion was used in 52 out of 2,172 patients.
  - There was a 25% in-hospital death rate in the endoaortic group versus 4.2% in others, which is statistically significant (p<0.0001).
  - Stroke incidence was 3.8% in the endoaortic group compared to 0.8% in others, with borderline significance (p=0.067).
  - Multivariable analysis showed an odds ratio of 5.609 for in-hospital death associated with endoaortic occlusion.
- **Strength and Reliability:**
  - The sample size for the endoaortic group is relatively small (52 patients), which may affect the generalizability.
  - The results show a strong association between endoaortic occlusion and increased mortality.
- **Relevance:**
  - The evidence directly addresses the safety concerns of using endoaortic balloon occlusion in the specified surgical context.

**3. Conclusion**
Based on the abstract, endoaortic balloon occlusion is associated with significantly higher in-hospital mortality and a potentially higher stroke rate compared to conventional methods. This suggests that it may not be a safe alternative.

**4. Final Answer**
**My final choice is: "no"**
GPT selected: no

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether endoaortic balloon occlusion is safe for managing the atherosclerotic ascending aorta. Key information to assess includes the safety outcomes (e.g., mortality, stroke) and technical efficacy (e.g., failure to occlude, complications) of endoaortic occlusion compared to conventional cross-clamping.  

**2. Evidence Evaluation**  
- **Mortality**: The in-hospital death rate was 25% in the endoaortic occlusion group, significantly higher than the 4.2% in other patients (p < 0.0001) and exceeded the expected 10.5% by the European risk evaluation system. Multivariable analysis confirmed endoaortic occlusion was independently associated with a 5.6-fold increased odds of death.  
- **Stroke**: The stroke rate was 3.8% in the endoaortic group versus 0.8% in others (p = 0.067), trending toward significance.  
- **Technical Failure**: In 19.2% of cases, the balloon failed (e.g., incomplete occlusion, exposure issues, rupture), necessitating a switch to cross-clamping.  

The studyâ€™s large sample size (52 patients in the intervention group) and statistical significance of mortality differences strengthen the evidence. The higher mortality and stroke risk, along with frequent technical failures, suggest endoaortic balloon occlusion may be unsafe in this context.  

**3. Conclusion**  
The data indicates endoaortic balloon occlusion is associated with significantly higher mortality and potential increased stroke risk compared to conventional methods, alongside frequent technical failures. This strongly suggests the technique is not safe in atherosclerotic ascending aorta management.  

**4. Final Answer:**  
**My final choice is: "no"**
Qwen selected: no

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether endoaortic balloon occlusion is safe for managing the atherosclerotic ascending aorta. Key points to evaluate include procedural effectiveness (e.g., occlusion success, technical complications) and clinical outcomes (e.g., mortality, stroke rates).  

**2. Evidence Evaluation**  
- **Procedural Issues**: Endoaortic occlusion failed in 19.2% of cases due to incomplete occlusion, hindered exposure, or balloon rupture, indicating technical unreliability.  
- **Mortality**: In-hospital death occurred in 25% of endoaortic occlusion patients, significantly higher than both the control group (4.2%, *p*<0.0001) and EuroSCORE predictions (10.5%, *p*=0.05). Multivariable analysis confirmed an independent association with death (OR=5.609).  
- **Stroke**: Stroke rate was 3.8% vs. 0.8% in controls, but the difference was only marginally significant (*p*=0.067).  
- **Conclusion**: The authors explicitly state that endoaortic occlusion was associated with higher mortality and a numerically elevated stroke risk, deeming it frequently ineffective and unsafe.  

**3. Conclusion**  
The study provides strong evidence that endoaortic balloon occlusion is unsafe in this setting, with statistically significant mortality risks and concerning procedural failure rates. While the stroke rate difference was not statistically definitive, the overall findings support a negative safety profile.  

**4. Final Answer**  
**My final choice is: no**
DeepSeek selected: no

Initial consensus: All models selected no